Line H Dohn, Benny V Jensen, Finn O Larsen. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabCamptothecin/administration & dosageCamptothecin/analogs & derivativesCapecitabineColorectal Neoplasms/drug therapyColorectal Neoplasms/mortalityColorectal Neoplasms/pathologyDeoxycytidine/administration & dosageDeoxycytidine/analogs & derivativesDrug Administration ScheduleFeasibility StudiesFluorouracil/administration & dosageFluorouracil/analogs & derivativesHumansInfusions, IntravenousLeucovorin/administration & dosageOrganoplatinum Compounds/administration & dosageOxaliplatinRetrospective StudiesSurvival AnalysisTime FactorsTreatment Outcome
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedOrganoplatinum CompoundsOxaliplatinDeoxycytidineBevacizumabCapecitabineLeucovorinFluorouracilCamptothecin
Year: 2010 PMID: 20001495 DOI: 10.3109/02841860903428184
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089